Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
Core EBITDA Margin

    Back to All Ratios
AARTI DRUGS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 11.3913.3620.4414.7013.51

What is the latest Core EBITDA Margin ratio of AARTI DRUGS ?

The latest Core EBITDA Margin ratio of AARTI DRUGS is 11.39 based on Mar2023 Consolidated results.
Year Core EBITDA Margin
Mar202311.39
Mar202213.36
Mar202120.44
Mar202014.70
Mar201913.51

How is Core EBITDA Margin of AARTI DRUGS Trending?

Years Core EBITDA Margin % Change
Mar2023 11.39
-14.75
Mar2022 13.36
-34.64
Mar2021 20.44
39.05
Mar2020 14.7
8.81
Mar2019 13.51 -

Other Financial Ratios of AARTI DRUGS


Compare Core EBITDA Margin ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹4,607.4 Cr -0.5% 9.6% 18.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-0.5%

9.6%

18.8%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses